CD276 and neoplasm: In HNSCC, the ADC MGC018 was particularly effective, reducing tumour volume by 98% and exhibiting a ‘bystander effect’, eliminating both B7-H3-expressing and adjacent non-B7-H3-expressing tumour cells [77].